Anlit Launches Omega-3 Focus at Vitafoods – Geneva

Anlit Ltd., Israel, launches Omega-3 Focus, a high-EPA supplement for children, in Geneva at the Finished Products Europe exhibition, co-located with Vitafoods, May 6-8, booth no. 10030. This new, innovative, omega-3 supplement for children is designed specifically to taste great while addressing their insufficient consumption of omega-3.

Mrs. Sigal Tepper, Scientific Director of Anlit will conduct a seminar at Vitafoods titled “Putting it into Practice – Omega 3 in kids Nutrition” Thursday, 8th of May, 10:30AM at the Exhibitor Presentation Theatre. Stressing the importance of omega-3 consumption for children, Tepper will cover practical aspects of the latest child-related omega-3 research.

EPA & DHA (eicosapentaenoic acid and docosahexaenoic acid) omega-3 fatty acids are well known for their importance to the development, function and health of the brain and nervous system. Interventional studies and meta-analyses substantiate the benefits of high-EPA omega-3 for children with neurodevelopmental disorders, improving reading, spelling, and behavior. Moreover, numerous studies published in the last decade demonstrate a correlation between low blood levels of EPA and DHA in children and various neurodevelopmental disorders, such as ADHD.

The consumption of fish—the main source of omega 3s—is declining among children, and the texture, taste and smell of omega-3 oil is often highly challenging.

Anlit’s Kidi Bites Technology overcomes challenges of unpleasant flavor and aroma, providing a tasty and healthy solution for kids. Anlit makes products targeting children’s taste and texture preferences, while providing essential health benefits. The delicious matrix, with a chocolate-like texture, overcomes children’s reluctance to taking nutritional supplements.

“Anlit is committed to providing healthy-yet-tasty supplement solutions, in a child-friendly format, to support optimal child growth,” says Shai Karlinski, Vice President of Sales and Marketing for Anlit. “Kids are more sensitive than adults to the appearance and texture of food and supplements. While adults can rationalize the necessity of taking supplements that might be unappealing in appearance, taste or texture, children are not bound by such considerations—they like flavorsome products that are smooth, soft and easy to chew.”

A new High EPA supplement in Anlit’s unique Kidi Bites form provides children with a delicious way of including a significant amount of essential omega-3 fatty acids in their daily diet.

Anlit’s High EPA supplement for children contains:

  • Delicious, fun, fish-shaped serving
  • No preservatives and no artificial coloring
  • Trans fat-free
  • Units packed safely in individually sealed blister packs

EFSA final aspartame evaluation as safe

Aspartame and its breakdown products are safe for human consumption at current levels of exposure, EFSA concludes in its first full risk assessment of this sweetener. To carry out its risk assessment, EFSA has undertaken a rigorous review of all available scientific research on aspartame and its breakdown products, including both animal and human studies.

 

“This opinion represents one of the most comprehensive risk assessments of aspartame ever undertaken. It’s a step forward in strengthening consumer confidence in the scientific underpinning of the EU food safety system and the regulation of food additives”, said the Chair of EFSA’s Panel on Food Additives and Nutrient Sources Added to Foods (ANS Panel), Dr Alicja Mortensen.

 

Experts of ANS Panel have considered all available information and, following a detailed analysis, have concluded that the current Acceptable Daily Intake (ADI) of 40mg/kg bw/day is protective for the general population. However, in patients suffering from the medical condition phenylketonuria (PKU), the ADI is not applicable, as they require strict adherence to a diet low in

 

English: aspartame; Asp-Phe methyl ester Deuts...
English: aspartame; Asp-Phe methyl ester Deutsch: Aspartam; Asp-Phe Methylester (Photo credit: Wikipedia)

 

(an amino acid found in proteins).

 

Following a thorough review of evidence provided both by animal and human studies, experts have ruled out a potential risk of aspartame causing damage to genes and inducing cancer. EFSA’s experts also concluded that aspartame does not harm the brain, the nervous system or affect behaviour or cognitive function in children or adults. With respect to pregnancy, the Panel noted that there was no risk to the developing fetus from exposure to phenylalanine derived from aspartame at the current ADI (with the exception of women suffering from PKU).

 

The opinion makes clear that the breakdown products of aspartame (phenylalanine, methanol and aspartic acid) are also naturally present in other foods (for instance, methanol is found in fruit and vegetables). The contribution of breakdown products of aspartame to the overall dietary exposure to these substances is low.

 

The opinion describes the criteria used to identify the studies relevant for the risk assessment and standards applied to evaluate the scientific evidence. EFSA’s experts examined all uncertainties related to the evaluation of aspartame. The opinion explains how these were addressed in the risk assessment to ensure that potential risks from aspartame were not underestimated.

 

The comprehensive review carried out by the ANS Panel was made possible following two public calls for data which made available a large body of scientific information, comprising both published and previously unpublished data and studies.

 

EFSA received over 200 comments during the public consultation on the draft opinion (that took place from 9 January 2013 to 15 February 2013) and all of these were considered. During the consultative phase EFSA also held a hearing with interested parties to discuss its draft opinion and the feedback received from the online public consultation. EFSA’s dialogue with stakeholders revealed that there were important aspects of the draft opinion that needed to be clarified in the final output.

 

EFSA is also publishing today the comments on the draft opinion received during the public consultation, its responses to the comments received and a statement on two recent publications, one from the US Environmental Protection Agency and the other Gift et al., that were brought to EFSA’s attention after the closure of the public consultation. Neither of these studies alters EFSA’s conclusion on aspartame.

 

 

(Source: EFSA Website)

 

Related articles